// App-Quantinova.ai

165 : Molecular characterization of heterogeneity in circulating tumor cells (CTCs) and tumor samples of metastatic castration-resistant prostate cancer (mCRPC) patients: The multicenter PETRUS program.

Researchers

Presenter

  • Christophe Massard

Principal Investigators

  • Marianne Oulhen

  • Sylvestre Le Moulec

  • Franoise Farace

  • Philippe Beuzeboc

  • Laurence Albiges

  • Stephane Culine

  • Stephane Oudard

  • Christophe Hennequin

  • Philippe Vielh

  • Karim Fizazi

  • Yohann Loriot

  • Nathalie Auger

Medical Centers

  • Val-de-Grace Hospital, Paris, France

  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, FranceHopital Saint-Louis, Paris, FranceMedical Oncology Department, Institut Curie, Paris, France

  • Institut Gustave-Roussy, Villejuif, France

  • Department of Medical Oncology, Hopital Saint-Louis, Paris, France

  • Institut de Cancerologie Gustave Roussy, Villejuif, France

  • Department of Medical Oncology, Hopital Europeen Georges Pompidou, Paris, France

  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France

  • Department of Biopathology. Gustave Roussy Cancer Campus, Villejuif, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved